Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol With Chemotherapy, Chemotherapy-Immunotherapy or Chemoradiation for Esophageal Adenocarcinoma
NCT04682158Phase 2Recruiting
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- Apr 2021
- Primary completion
- Apr 2031
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of propranolol in esophageal adenocarcinoma (EAC), sponsored by Roswell Park Comprehensive Cancer Center. Started Apr 2021; status: recruiting.
02
Drugs
propranolol
03
Conditions
esophageal adenocarcinoma (EAC)
Beyond the preview
Go deeper on NCT04682158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04682158.